» Articles » PMID: 29903047

Bone Marrow Characterization in COPD: a Multi-level Network Analysis

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2018 Jun 16
PMID 29903047
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bone marrow (BM) produces hematopoietic and progenitor cells that contribute to distant organ inflammation and repair. Chronic obstructive pulmonary disease (COPD) is characterized by defective lung repair. Yet, BM composition has not been previously characterized in COPD patients.

Methods: In this prospective and controlled study, BM was obtained by sternum fine-needle aspiration in 35 COPD patients and 25 healthy controls (10 smokers and 15 never-smokers). BM cell count and immunophenotype were determined by microscopy and flow cytometry, respectively. Circulating inflammatory (C-reactive protein, IL-6, IL-8) and repair markers (HGF, IGF, TGF-β, VEGF) were quantified by ELISA. Results were integrated by multi-level network correlation analysis.

Results: We found that: (1) there were no major significant pair wise differences between COPD patients and controls in the BM structural characteristics; (2) multi-level network analysis including patients and controls identifies a relation between immunity, repair and lung function not previously described, that remains in the COPD network but is absent in controls; and (3) this novel network identifies eosinophils as a potential mediator relating immunity and repair, particularly in patients with emphysema.

Conclusions: Overall, these results suggest that BM is activated in COPD with impaired repair capacity in patients with more emphysema and/or higher circulating eosinophils.

Citing Articles

Mesenchymal Stromal Cells From Emphysematous Donors and Their Extracellular Vesicles Are Unable to Reverse Cardiorespiratory Dysfunction in Experimental Severe Emphysema.

Antunes M, Braga C, Oliveira T, Kitoko J, Castro L, Xisto D Front Cell Dev Biol. 2021; 9:661385.

PMID: 34136481 PMC: 8202416. DOI: 10.3389/fcell.2021.661385.


Integrating Comorbidities and Phenotype-Based Medicine in Patient-Centered Medicine in COPD.

Lopez-Campos J, Ruiz-Duque B, Carrasco-Hernandez L, Caballero-Eraso C J Clin Med. 2020; 9(9).

PMID: 32854364 PMC: 7565552. DOI: 10.3390/jcm9092745.


Eosinophil-derived IL-13 promotes emphysema.

Doyle A, Mukherjee M, LeSuer W, Bittner T, Pasha S, Frere J Eur Respir J. 2019; 53(5).

PMID: 30728205 PMC: 7313423. DOI: 10.1183/13993003.01291-2018.

References
1.
Faner R, Cruz T, Casserras T, Lopez-Giraldo A, Noell G, Coca I . Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in Emphysema. Am J Respir Crit Care Med. 2016; 193(11):1242-53. DOI: 10.1164/rccm.201507-1311OC. View

2.
Peichev M, Naiyer A, Pereira D, Zhu Z, Lane W, Williams M . Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000; 95(3):952-8. View

3.
Cosio B, Soriano J, Lopez-Campos J, Calle-Rubio M, Soler-Cataluna J, de-Torres J . Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort. Chest. 2015; 149(1):45-52. DOI: 10.1378/chest.15-1055. View

4.
Rafii S, Lyden D . Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003; 9(6):702-12. DOI: 10.1038/nm0603-702. View

5.
Di Stefano A, Sangiorgi C, Gnemmi I, Casolari P, Brun P, Ricciardolo F . TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD. Chest. 2018; 153(4):851-862. PMC: 5883327. DOI: 10.1016/j.chest.2017.12.017. View